Related Experiment Video
Updated: Sep 7, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Soft-tissue Sarcoma Survival in the US Military Health System: Comparison With the SEER Program
Ashley B Anderson1, Amie B Park, Kangmin Zhu
1From the Department of Surgery, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center (Dr. Anderson, Dr. Park, Dr. Zhu, Dr. Lin, Dr. Shriver, and Dr. Potter); the Henry M. Jackson Foundation for the Advancement of Military Medicine (Dr. Park, Dr. Zhu, and Dr. Lin); the John P. Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences and Walter Reed National Military Medical Center (Dr. Zhu, Dr. Lin, and Dr. Shriver); and the Department of Preventive Medicine and Biostatistics (Dr. Zhu and Dr. Lin), Uniformed Services University of the Health Sciences.
Introduction:
The US Military Health System (MHS) provides universal health care to beneficiaries. Few studies have evaluated the potential influence of access to universal care on survival outcomes for sarcoma. This study compared the survival of adult patients with soft-tissue sarcoma in the MHS with the US general population.
Methods:
MHS data were obtained from the Department of Defense Automated Central Tumor Registry (ACTUR). US population data were obtained from the National Cancer Institute's Surveillance, Epidemiology, and End Results registry. Patients who were 25 years or older with a histologically confirmed musculoskeletal soft-tissue sarcoma were matched based on age, sex, and race. Kaplan-Meier survival curves and Cox proportional hazards models were used to compare 5-year survival in the two groups.
Results:
Adult patients in ACTUR had markedly lower 5-year mortality for soft-tissue sarcomas (hazard ratio=0.82; 95% confidence interval, 0.73 to 0.92) after adjustment for potential confounders. Lower 5-year mortality was found in most demographic subgroups for ACTUR patients compared with Surveillance, Epidemiology, and End Results patients.
Conclusion:
Five-year survival in the MHS compared with the US general population may suggest an important role of universal health care in improving the survival of patients with soft-tissue sarcoma.
More Related Videos
07:15A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis
Kaplan-Meier Approach
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...